1-[(1R,3S,5S)-rel-3-amino-8-azabicyclo[3.2.1]octan-8-yl]ethan-1-one

Catalog No. :
ACQRIP318
CAS No. :
1256262-45-9
Molecular Formula :
C9H16N2O
Molecular Weight :
168.24

IUPAC Name:1-((1R,3s,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl)ethan-1-one

1-[(1R,3S,5S)-rel-3-amino-8-azabicyclo[3.2.1]octan-8-yl]ethan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$203.00Login to see priceInquiryInquiry
250mg98%$324.00Login to see priceInquiryInquiry
1g98%$811.00Login to see priceInquiryInquiry
5g98%$2435.00Login to see priceInquiryInquiry
10g98%$4060.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[(1R,3S,5S)-rel-3-amino-8-azabicyclo[3.2.1]octan-8-yl]ethan-1-one
IUPAC Name1-((1R,3s,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl)ethan-1-one
Molecular FormulaC9H16N2O
Molecular Weight168.24
SMILESCC(N1[C@@]2([H])C[C@@H](N)C[C@]1([H])CC2)=O
InChI KeyFBCWQRRMRIKGKS-PSVAKVPMSA-N
Synonym1-[(1R,3S,5S)-rel-3-amino-8-azabicyclo[3.2.1]octan-8-yl]ethan-1-one;Ethanone, 1-[(3-exo)-3-amino-8-azabicyclo[3.2.1]oct-8-yl]-;1-((1r,3s,5s)-3-amino-8-azabicyclo[3.2.1]octan-8-yl)ethan-1-one
CAS No.1256262-45-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQRIP318 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQRIP318 route product structure diagram
    ACQRIP3181256262-45-9
Inquiry

2. ACQRIP318 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQRIP318 route product structure diagram
    ACQRIP3181256262-45-9
Inquiry

Comments (0)